Sinovac Biotech Gross Profit Growth & History (SVA)

Sinovac Biotech's gross profit was $262.0M for fiscal 2025.

View full Sinovac Biotech company overview

Sinovac Biotech annual gross profit history

Sinovac Biotech annual gross profit

Fiscal yearPeriod endedGross profitChangeGrowth
20252025-12-31$262.0M$41.3M+18.71%
20242024-12-31$220.7M−$102.6M−31.74%
20232023-12-31$323.3M−$491.9M−60.34%
20222022-12-31$815.2M−$17.56B−95.56%
20212021-12-31$18.38B$17.93B+4044.03%
20202020-12-31$443.4M$229.9M+107.62%
20192019-12-31$213.6M$8.7M+4.22%
20182018-12-31$204.9M$50.8M+32.98%
20172017-12-31$154.1M$104.1M+207.98%
20162016-12-31$50.0M$1.0M+2.11%
20152015-12-31$49.0M$1.6M+3.27%
20142014-12-31$47.5M−$3.8M−7.44%
20132013-12-31$51.3M$21.2M+70.24%
20122012-12-31$30.1M−$5.6M−15.67%
20112011-12-31$35.7M$19.0M+114.08%
20102010-12-31$16.7M−$47.5M−73.99%
20092009-12-31$64.1M

Sinovac Biotech gross profit trends

Over the last five fiscal years, Sinovac Biotech's gross profit decreased from $443.4M to $262.0M, a change of −$181.5M.

About the metric

What gross profit means

Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.

Calculation and source

SEC-reported and calculated gross profit

TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Sinovac Biotech source filings ↗

Community posts

It’s quiet here.

No posts about SVA yet. Start the conversation.

Write the first post